The Food and Drug Administration (FDA) is responsible for assuring that medical devices are safe and effective before they go on the market. As part of its assessment of FDA's premarket clearance process for medical devices, the IOM held a workshop June 14-15 to discuss how to best balance patient safety and technological innovation. This document summarizes the workshop.Table of ContentsFront Matter1 Introduction2 Legislative History of the Medical Device Amendments of 19763 Premarket Notification4 The Medical Device Industry Innovation Ecosystem5 The Global Framework for Regulation of Medical Devices6 Public CommentsAppendix A: Workshop AgendaAppendix B: Biographic Information on Invited Speakers, Panelists, and Authors of Commissioned PapersAppendix C: Premarket Notification: A Key Element of US Medical Device Regulation--Larry Kessler and Philip J. PhillipsAppendix D: Impact of the Regulatory Framework on Medical Device Development and Innovation--David W. Feigal, Jr.